Evan Bayh's wife works for Wellpoint. How about Joe's wife?
Hadassah LiebermanHadassah Lieberman joined the Hill & Knowlton public relations firm in March 2005. "The legendary lobbying and PR firm hired her as a 'senior counselor' in its 'health and pharmaceuticals practice'," Joe Conason wrote July 12, 2006, in Truthdig, marking her "return to consulting after more than a decade of retirement."
Lieberman, a daughter of Holocaust survivors and a naturalized U.S. Citizen, is the wife of Joseph I. Lieberman, a Democrat and the Junior U.S. Senator from Connecticut.
Hadassah Lieberman "earned a master’s degree in international relations from Northeastern University (1971), worked at Hill & Knowlton public relations as a senior counselor in health and pharmaceuticals and has frequently delivered speeches on women’s health care," Jennifer Medina wrote August 14, 2006, in the New York Times.
Hadassah Lieberman "developed an Advisory Network for Women's Health whose Sister to Sister Network promotes awareness and prevention of heart disease (1998-2000). She has also worked at HFL & Associates (1997-98); APCO Associates (1993-97); the National Research Council (1) (1990-93); Pfizer Pharmaceuticals (1982-85); Hoffmann-La Roche (1972-81); and Lehman Brothers (1971-72)," according to an American Council of Life Insurers (ACLI) interview published July 10, 2001, in the Washington Post.
Lieberman was Senior Program Officer at the National Research Council (1990-1993); Director of Policy, Planning and Communications at Pfizer (1982-1985); and a Research Analyst at Lehman Brothers (1971-1972), according to NNDB.com. (2)
<snip>
"When a senator’s wife works for one of the capital’s largest lobby shops, appearances tend to matter. In this case, something happened immediately that didn’t look very good," Joe Conason wrote July 12, 2006, in Truthdig.
"Lieberman signed up with Hill & Knowlton in March 2005. The firm’s clients included GlaxoSmithKline, the British pharmaceutical giant that manufactures flu vaccines along with many other drugs. In April 2005, Sen. Lieberman introduced a bill that would award an array of new government 'incentives' to companies like GSK to produce more vaccines—notably patent extensions on other products, at a cost of billions to governments and consumers.
"That legislation provoked irritated comment by his hometown newspaper, the New Haven Register. In an editorial headlined 'Lieberman Crafts Drug Company Perk,' the Register noted that his bill was even more generous to the pharmaceutical industry than a similar proposal by the Senate Republican leadership. 'The government can offer incentives and guarantees for needed public health measures,' said the editorial. 'But it should not write a blank check, as these bills do, to the pharmaceutical industry that has such a large cost to the public with what may be an uncertain or dubious return.'
http://www.sourcewatch.org/index.php?title=Hadassah_Lieberman